Related references
Note: Only part of the references are listed.Cell-Type-Specific CRISPR/Cas9 Delivery by Biomimetic Metal Organic Frameworks
Mram Z. Alyami et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles
Jia Zhuang et al.
SCIENCE ADVANCES (2020)
Nanoscale ATP-Responsive Zeolitic Imidazole Framework-90 as a General Platform for Cytosolic Protein Delivery and Genome Editing
Xiaoti Yang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
A tumor-targeted immune checkpoint blocker
Yuhan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
Wen-Long Liu et al.
NATURE COMMUNICATIONS (2019)
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
Patrick Williams et al.
CANCER (2019)
Enhanced Activity of Enzymes Encapsulated in Hydrophilic Metal-Organic Frameworks
Weibin Liang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Emerging Nano-/Microapproaches for Cancer Immunotherapy
Yu Mi et al.
ADVANCED SCIENCE (2019)
Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework
Shahad K. Alsaiari et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Biomineralized Metal-Organic Framework Nanoparticles Enable Intracellular Delivery and Endo-Lysosomal Release of Native Active Proteins
Ting-Ting Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
PD-1/PD-L1 checkpoint in hematological malignancies
O. Annibali et al.
LEUKEMIA RESEARCH (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
Chun Gwon Park et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients
Bei Jia et al.
BLOOD CANCER JOURNAL (2018)
Delivery Strategies for Immune Checkpoint Blockade
Qian Chen et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Hua Wang et al.
NATURE MATERIALS (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Shielding against Unfolding by Embedding Enzymes in Metal-Organic Frameworks via a de Novo Approach
Fu-Siang Liao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
Jun Ishihara et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy
David M. Francis et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy
Rinat Meir et al.
ACS NANO (2017)
A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy
Fei Duan et al.
BIOMATERIALS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
One-pot Synthesis of Metal Organic Frameworks with Encapsulated Target Molecules and Their Applications for Controlled Drug Delivery
Haoquan Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Chao Wang et al.
NANO LETTERS (2016)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy (vol 13, pg 273, 2016)
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Toward Design Rules for Enzyme Immobilization in Hierarchical Mesoporous Metal-Organic Frameworks
Peng Li et al.
CHEM (2016)
Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging
Rinat Meir et al.
ACS NANO (2015)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia
Maciej Grzywnowicz et al.
LEUKEMIA & LYMPHOMA (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules
Kang Liang et al.
NATURE COMMUNICATIONS (2015)
Nanoscale Metal-Organic Frameworks for the Co-Delivery of Cisplatin and Pooled siRNAs to Enhance Therapeutic Efficacy in Drug-Resistant Ovarian Cancer Cells
Chunbai He et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
One-Pot Synthesis of Protein-Embedded Metal-Organic Frameworks with Enhanced Biological Activities
Fengjiao Lyu et al.
NANO LETTERS (2014)
Immune system targeting by biodegradable nanoparticles for cancer vaccines
Joana M. Silva et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Metal-Organic Frameworks in Biomedicine
Patricia Horcajada et al.
CHEMICAL REVIEWS (2012)
Programmed Death-1 and Its Ligand Are Novel Immunotolerant Molecules Expressed on Leukemic B Cells in Chronic Lymphocytic Leukemia
Maciej Grzywnowicz et al.
PLOS ONE (2012)